Skip to main content
Top
Published in: Supportive Care in Cancer 12/2004

01-12-2004 | Supportive Care International

The Hospital Anxiety and Depression Scale in Greek cancer patients: psychometric analyses and applicability

Authors: Kyriaki Mystakidou, Eleni Tsilika, Efi Parpa, Emmanuela Katsouda, Antonis Galanos, Lambros Vlahos

Published in: Supportive Care in Cancer | Issue 12/2004

Login to get access

Abstract

Goals of work

The aim of the present study was to validate the Greek version of the Hospital Anxiety and Depression Scale (HAD) in a palliative care unit.

Patients and methods

The scale was translated with the “forward-backward” procedure to Greek. It was administered twice, with a 1-week interval, to 120 patients with advanced cancer. Together with the HAD scale, the patients also completed the Spielberger State-Anxiety Scale (STAI-S).

Main results

Factor analyses identified a two-factor solution corresponding to the original two subscales of the HAD, which were found to be correlated. The Greek version of the HAD had Cronbach’s alphas for the anxiety and depression scales of 0.887 and 0.703, respectively. Validity as performed using known-group analysis showed good results. Both anxiety and depression subscales discriminated well between subgroups of patients differing in disease severity as defined by ECOG performance status. Correlations between the HAD scale and the STAI-S was 0.681 for the anxiety subscale and 0.485 for the depression subscale.

Conclusions

These psychometric properties of the Greek version of the HAD scale confirm it as a valid and reliable measure when administered to patients with advanced cancer.
Literature
1.
go back to reference Abiafun OA (1994) A validity study of the Hospital Anxiety and Depression Scale in general hospital units and a community sample in Nigeria. Br J Psychiatry 35:257–264 Abiafun OA (1994) A validity study of the Hospital Anxiety and Depression Scale in general hospital units and a community sample in Nigeria. Br J Psychiatry 35:257–264
2.
go back to reference Bottomley A (1998) Depression in cancer patients: a literature review. Eur J Cancer 7:181–191CrossRef Bottomley A (1998) Depression in cancer patients: a literature review. Eur J Cancer 7:181–191CrossRef
3.
go back to reference Constantini M, Musso M, Viterbori P, Bonci F, DelMastro L, Garrone O, Venturini M, Morasso G (1999) Detecting psychological distress in cancer patients: validity of the Italian version of the Hospital Anxiety and Depression scale. Support Care Cancer 7:121–127CrossRefPubMed Constantini M, Musso M, Viterbori P, Bonci F, DelMastro L, Garrone O, Venturini M, Morasso G (1999) Detecting psychological distress in cancer patients: validity of the Italian version of the Hospital Anxiety and Depression scale. Support Care Cancer 7:121–127CrossRefPubMed
4.
go back to reference Cronbach LJ (1951) Coefficient alpha and the internal structure of test. Psychometrica 16:297–334 Cronbach LJ (1951) Coefficient alpha and the internal structure of test. Psychometrica 16:297–334
5.
go back to reference El Rufaie OE, Albar AA, al Dabal BK (1988) Identifying anxiety and depressive disorders among primary care patients: a pilot study. Acta Psychiatr Scand 77:280–282PubMed El Rufaie OE, Albar AA, al Dabal BK (1988) Identifying anxiety and depressive disorders among primary care patients: a pilot study. Acta Psychiatr Scand 77:280–282PubMed
6.
go back to reference Herrmann C (1997) International experiences with the Hospital Anxiety and Depression Scale. A review of validation data and clinical results. J Psychosom Res 42:17–41CrossRefPubMed Herrmann C (1997) International experiences with the Hospital Anxiety and Depression Scale. A review of validation data and clinical results. J Psychosom Res 42:17–41CrossRefPubMed
7.
go back to reference Keedwell P, Snaith RP (1996) What do anxiety scales measure? Acta Psychiatr Scand 93:177–180PubMed Keedwell P, Snaith RP (1996) What do anxiety scales measure? Acta Psychiatr Scand 93:177–180PubMed
8.
go back to reference Kessler RC, Nelson CB, McGonagle KA, Liu J, Swartz M, Blazer DG (1996) Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey. Br J Psychiatry Suppl 30:17–30PubMed Kessler RC, Nelson CB, McGonagle KA, Liu J, Swartz M, Blazer DG (1996) Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey. Br J Psychiatry Suppl 30:17–30PubMed
9.
go back to reference Klein DF (1974) Endogenomorphic depression. Arch Gen Psychiatry 31:447–454PubMed Klein DF (1974) Endogenomorphic depression. Arch Gen Psychiatry 31:447–454PubMed
10.
go back to reference Lowe B, Sitzer RL, Grafe K, Kroenke K, Quenter A, Zipfel S, Buchholz C, Witte S, Herzog W (2004) Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians’ diagnoses. J Affect Disord 78(2):131–140CrossRefPubMed Lowe B, Sitzer RL, Grafe K, Kroenke K, Quenter A, Zipfel S, Buchholz C, Witte S, Herzog W (2004) Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians’ diagnoses. J Affect Disord 78(2):131–140CrossRefPubMed
11.
go back to reference Malasi TH, Mirza IA, el Islam MF (1991) Validation of the Hospital Anxiety and Depression Scale in Arab patients. Acta Psychiatr Scand 84:323–326PubMed Malasi TH, Mirza IA, el Islam MF (1991) Validation of the Hospital Anxiety and Depression Scale in Arab patients. Acta Psychiatr Scand 84:323–326PubMed
12.
go back to reference Moffic HS, Paykel ES (1975) Depression in medical in-patients. Br J Psychiatry 126:346–353PubMed Moffic HS, Paykel ES (1975) Depression in medical in-patients. Br J Psychiatry 126:346–353PubMed
13.
go back to reference Mumford DB, Tareen IA, Bajwa MA, Bhatti MR, Karim R (1991) The translation and evaluation of an Urdu version of the Hospital Anxiety and Depression scale. Acta Psychiatr Scand 83:81–85PubMed Mumford DB, Tareen IA, Bajwa MA, Bhatti MR, Karim R (1991) The translation and evaluation of an Urdu version of the Hospital Anxiety and Depression scale. Acta Psychiatr Scand 83:81–85PubMed
14.
go back to reference Nunnally J, Bernstein I (1994) Psychometric theory. McGraw-Hill, New York Nunnally J, Bernstein I (1994) Psychometric theory. McGraw-Hill, New York
15.
go back to reference Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649–655PubMed Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649–655PubMed
16.
go back to reference Ormel J, Oldenhinkel AJ, Goldberg DP, Hadiamont PPG, Wilmink FW, Bridges K (1995) The structure of common psychiatric symptoms: how many dimensions of neurosis? Psychol Med 25:521–530PubMed Ormel J, Oldenhinkel AJ, Goldberg DP, Hadiamont PPG, Wilmink FW, Bridges K (1995) The structure of common psychiatric symptoms: how many dimensions of neurosis? Psychol Med 25:521–530PubMed
17.
go back to reference Razavi D, Stiefel F (1994) Common psychiatric disorders in cancer patients. Adjustment disorders and depressive disorders. Support Care Cancer 2:223–232PubMed Razavi D, Stiefel F (1994) Common psychiatric disorders in cancer patients. Adjustment disorders and depressive disorders. Support Care Cancer 2:223–232PubMed
18.
go back to reference Sartorius N, Ustun TB, Lecrubier Y, Wittchen HU (1996) Depression comorbid with anxiety: results from the WHO study on psychological disorders in primary health care. Br J Psychiatry Suppl (30):38–43 Sartorius N, Ustun TB, Lecrubier Y, Wittchen HU (1996) Depression comorbid with anxiety: results from the WHO study on psychological disorders in primary health care. Br J Psychiatry Suppl (30):38–43
19.
go back to reference Sensky T (1988) Measurement of the quality of life in end-stage renal failure. N Engl J Med 319:1353 Sensky T (1988) Measurement of the quality of life in end-stage renal failure. N Engl J Med 319:1353
20.
go back to reference Snaith RP (1993) What do depression scales measure? Br J Psychiatry 163:293–298PubMed Snaith RP (1993) What do depression scales measure? Br J Psychiatry 163:293–298PubMed
21.
22.
go back to reference Snaith RP, Baugh SJ, Clayden AD, Hussain A, Sipple M (1982) The Clinical Anxiety scale: a modification of the Hamilton Anxiety scale. Br J Psychiatry 141:518–523PubMed Snaith RP, Baugh SJ, Clayden AD, Hussain A, Sipple M (1982) The Clinical Anxiety scale: a modification of the Hamilton Anxiety scale. Br J Psychiatry 141:518–523PubMed
23.
go back to reference Spielberger CD, Gorsuch RL, Lushene RE (1970) Manual of the State-Trait Anxiety Inventory. Consulting Psychologists Press, Palo Alto, CA Spielberger CD, Gorsuch RL, Lushene RE (1970) Manual of the State-Trait Anxiety Inventory. Consulting Psychologists Press, Palo Alto, CA
24.
go back to reference Underwood MJ, Firmin RK, Jehn D (1993) Aspects of psychological and social morbidity in patients awaiting coronary artery bypass grafting. Br Heart J 69:383–384 Underwood MJ, Firmin RK, Jehn D (1993) Aspects of psychological and social morbidity in patients awaiting coronary artery bypass grafting. Br Heart J 69:383–384
25.
go back to reference Zigmond AS, Snaith RP (1983) The Hospital Anxiety and Depression scale (validity and reliability). Acta Psychiatr Scand 67:361–370PubMed Zigmond AS, Snaith RP (1983) The Hospital Anxiety and Depression scale (validity and reliability). Acta Psychiatr Scand 67:361–370PubMed
Metadata
Title
The Hospital Anxiety and Depression Scale in Greek cancer patients: psychometric analyses and applicability
Authors
Kyriaki Mystakidou
Eleni Tsilika
Efi Parpa
Emmanuela Katsouda
Antonis Galanos
Lambros Vlahos
Publication date
01-12-2004
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 12/2004
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-004-0698-y

Other articles of this Issue 12/2004

Supportive Care in Cancer 12/2004 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine